Drugs and the neuroscience of behavior : an introduction to psychopharmacology /: an introduction to psychopharmacology. (2020)

• Record Type: Book
• Further Information: Note: Adam Prus.
• Authors: Prus, Adam J
• Contents: Chapter 1: Introduction to Psychopharmacology; Psychopharmacology; Why Read a Book on Psychopharmacology?; What is a Drug?; Psychoactive Drugs are Described by Manner of Use; Generic Names, Brand Names, and Street Names for Drugs; Drug Effects Correspond with Dose; Pharmacodynamics, Pharmacokinetics, and Pharmacogenetics; Objective and Subjective Effects of Psychoactive Drugs; Study Designs and the Assessment of Psychoactive Drugs; Validity and the Interpretation of Study Findings; Ethical Considerations in Research; FROM ACTIONS TO EFFECTS: Therapeutic Drug Development; CHAPTER SUMMARY; KEY TERMS; Chapter 2: The Nervous System; Cells in the Nervous System; The Nervous System; Cerebral Blood Flow and Cerebrospinal Fluid; Genes and the Physiological Processes of Cells; FROM ACTIONS TO EFFECTS: Advances in Therapeutic Use of CRISPR Genetic; Technology; CHAPTER SUMMARY; KEY TERMS; Chapter 3: Neurotransmission; Electrical Events Within a Neuron and the Release of Neurotransmitters; Electrical Potentials Along Axons; Propagation of Action Potentials Down Axons; Neurotransmitters: Signalling Molecules for Neuronal Communication; Neurotransmitters and Receptors; Types of Neurotransmitters; Acetylcholine; Neuropeptides: A Large Class of Neurotransmitters; Other Types of Chemical Transmission in the Nervous System; FROM ACTIONS TO EFFECTS: Probiotics and Mental Health; CHAPTER SUMMARY; KEY TERMS; Chapter 4: Properties of Drugs; Pharmacokinetic Properties of Drugs; Pharmacodynamic Properties of Drugs; Psychoactive Drugs and Receptors; Adaptations to Chronic Drug Use; FROM ACTIONS TO EFFECTS: Environmental Neurotoxicology; CHAPTER SUMMARY; KEY TERMS; Chapter 5: Drugs of Abuse; Regulatory Agencies and Drug Classification; Clinical Definitions and the Diagnosis of Drug Addiction; Theoretical Models and the Features of Drug Addiction; Drugs of Abuse and Reward Circuitry; Chronic Use of Abused Substances and Changes to Learning and Memory Systems; Neurobiology and the Stages of Drug Addiction; Mortality and Drug Addiction; Psychological and Pharmacological Therapies for Treating Drug Addiction; FROM ACTIONS TO EFFECTS: Food Addiction; CHAPTER SUMMARY; KEY TERMS; Chapter 6: Psychostimulants; Psychostimulants: Herbal Remedies, Prescription Drugs, and Substances of Abuse; Pharmacokinetics of Psychostimulants; Psychostimulants and Monoamine Neurotransmitters; Pharmacological Effects of Psychostimulants186; Treatments of Psychostimulant Addiction; FROM ACTIONS TO EFFECTS: Psychostimulants as Cognitive Enhancers and Treatments for ADHD; CHAPTER SUMMARY; KEY TERMS; Chapter 7: Nicotine and Caffeine; Nicotine and Tobacco; History of Tobacco; Pharmacokinetic Properties of Tobacco; Nicotine and Nervous System Functioning; Nicotine’s Pharmacological Effects; Environmental, Genetic, and Receptor Differences Between Light and Heavy Tobacco Users; FROM ACTIONS TO EFFECTS: Why People Smoke and How They Quit Caffeine; Caffeine Absorption, Duration, and Interaction with Other Psychoactive Drugs; Caffeine: Antagonist for Adenosine Receptors; Caffeine: Mild Psychostimulant Effects; Tolerance and Withdrawl During Sustained Caffeine Use; FROM ACTIONS TO EFFECTS: Caffeine Habit?; CHAPTER SUMMARY; KEY TERMS; Chapter 8: Depressants; Types of Depressant Substances; Depressants and GABA Neurotransmission; Barbiturates; Neurotransmission; Benzodiazepines; Receptors; Z-drugs; GHB; Inhalants; FROM ACTIONS TO EFFECTS: Stimulus Properties of GHB and Toluene; CHAPTER SUMMARY; KEY TERMS; Chapter 9: Alcohol; Alcohol: The Most Commonly Used Depressant Substance; Alcohol Production Through Fermentation and Distillation; History of Alcohol; Pharmacokinetic Factors and Alcohol’s Effects; Alcohol and Interactions with Other Drugs; Alcohol and Central Nervous System Functioning; Pharmacological Effects of Alcohol; Treating Alcohol Addiction; FROM ACTIONS TO EFFECTS: Hangover; CHAPTER SUMMARY; KEY TERMS; Chapter 10: Opioids; Opioids: Natural and Synthetic; History of Opioid Use; Pharmacokinetic Properties and Opioid Abuse; Opioid Drugs and the Endogenous Opioid System; Opioid Drugs are Classified by Receptor Actions; Opioids and Reward, Pain, and Stress Systems; Opioid Rewarding and Analgesic Effects; FROM ACTIONS TO EFFECTS: Pharmacological Approaches for Treating Opioid Addiction; CHAPTER SUMMARY; KEY TERMS; Chapter 11: Cannabinoids; Historical Use of Cannabis; Methods of Cannabis Preparation and Use; Cannabinoid Compounds and the Endocannabinoid System; Cannabinoids and CB1 and CB2 Receptors; Physiological Effects of Cannabinoids; Behavioral and Cognitive Effects of Cannabinoids; Subjective Effects of Cannabinoids; Cannabis Use Disorder; Health Risks of Cannabis; FROM ACTIONS TO EFFECTS: Medical Use of Cannabinoids; CHAPTER SUMMARY; KEY TERMS; Chapter 12: Psychedelic Drugs; Hallucinogens; Mixed Stimulant–Psychedelic Drugs; Dissociative Anesthetics; Other Psychedelic Drugs; FROM ACTIONS TO EFFECTS: Synesthesia; CHAPTER SUMMARY; KEY TERMS; Chapter 13: Treatments for Depression and Bipolar Disorder; Mental Disorders; Depression; Pharmacogenetic Factors in Antidepressant Treatment; Combination Drug Strategies for Treating Depression; Combining Psychotherapy and Pharmacotherapy for Treating Depression; Bipolar Disorder; FROM ACTIONS TO EFFECTS: Psychedelic Drugs for Treating Depression; CHAPTER SUMMARY; KEY TERMS; Chapter 14: Treatments for Anxiety Disorders; Anxiety Disorders; Structures Involved in Fear and Anxiety; Anxious Feelings, the Amygdala, and the Sympathetic Nervous System; Stress and the HPA Axis; Anxiolytic Drugs for the Treatment of Anxiety; Antidepressant Drugs for the Treatment of Anxiety Disorders; MDMA Treatment for Post-traumatic Stress Disorder; FROM ACTIONS TO EFFECTS: How Do Antidepressant Drugs Reduce Anxiety?; CHAPTER SUMMARY; KEY TERMS; Chapter 15: Antipsychotic Drugs; Schizophrenia; Schizophrenia’s Complex Neurobiological Profile; A Brief History of Schizophrenia and Its Treatment; Neurotransmission Hypotheses for Schizophrenia; Typical and Atypical Antipsychotic Drugs; Antipsychotic Drugs and Autism; FROM ACTIONS TO EFFECTS: Antipsychotic Drug Actions and Neurotransmission in Schizophrenia; CHAPTER SUMMARY; KEY TERMS;
• Edition: Third edition
• Publisher Details: Los Angeles : SAGE
• Publication Date: 2020
• Extent: 1 online resource
• Subjects: 615.788; Psychopharmacology; Psychotropic drugs -- Side effects
• Languages: English
• ISBNs: 9781544362588
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.